Literature DB >> 9083081

Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21(waf1/cip1) and p27(kip1) and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells.

M R Frey1, M L Saxon, X Zhao, A Rollins, S S Evans, J D Black.   

Abstract

The molecular mechanisms underlying protein kinase C (PKC) isozyme-mediated control of cell growth and cell cycle progression are poorly understood. Our previous analysis of PKC isozyme regulation in the intestinal epithelium in situ revealed that multiple members of the PKC family undergo changes in expression and subcellular distribution precisely as the cells cease proliferating in the mid-crypt region, suggesting that activation of one or more of these molecules is involved in negative regulation of cell growth in this system (Saxon, M. L., Zhao, X., and Black, J. D. (1994) J. Cell Biol. 126, 747-763). In the present study, the role of PKC isozyme(s) in control of intestinal epithelial cell growth and cell cycle progression was examined directly using the IEC-18 immature crypt cell line as a model system. Treatment of IEC-18 cells with PKC agonists resulted in translocation of PKC alpha, delta, and epsilon from the soluble to the particulate subcellular fraction, cell cycle arrest in G1 phase, and delayed transit through S and/or G2/M phases. PKC-mediated cell cycle arrest in G1 was accompanied by accumulation of the hypophosphorylated, growth-suppressive form of the retinoblastoma protein and induction of the cyclin-dependent kinase inhibitors p21(waf1/cip1) and p27(kip1). Reversal of these cell cycle regulatory effects was coincident with activator-induced down-regulation of PKC alpha, delta, and epsilon. Differential down-regulation of individual PKC isozymes revealed that PKC alpha in particular is sufficient to mediate cell cycle arrest by PKC agonists in this system. Taken together, the data implicate PKC alpha in negative regulation of intestinal epithelial cell growth both in vitro and in situ via pathways which involve modulation of Cip/Kip family cyclin-dependent kinase inhibitors and the retinoblastoma growth suppressor protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083081     DOI: 10.1074/jbc.272.14.9424

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Lipin-1 expression is critical for keratinocyte differentiation.

Authors:  Minjung Chae; Ji-Yong Jung; Il-Hong Bae; Hyoung-June Kim; Tae Ryong Lee; Dong Wook Shin
Journal:  J Lipid Res       Date:  2015-12-13       Impact factor: 5.922

2.  Activation of extracellular signal-regulated kinase (ERK) in G2 phase delays mitotic entry through p21CIP1.

Authors:  S Dangi; F M Chen; P Shapiro
Journal:  Cell Prolif       Date:  2006-08       Impact factor: 6.831

3.  Protein kinase Cα signaling regulates inhibitor of DNA binding 1 in the intestinal epithelium.

Authors:  Fang Hao; Marybeth A Pysz; Kathryn J Curry; Kristin N Haas; Steven J Seedhouse; Adrian R Black; Jennifer D Black
Journal:  J Biol Chem       Date:  2011-03-18       Impact factor: 5.157

Review 4.  Protein kinase C as a tumor suppressor.

Authors:  Alexandra C Newton
Journal:  Semin Cancer Biol       Date:  2017-05-02       Impact factor: 15.707

5.  Protein kinase Cα gain-of-function variant in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation.

Authors:  Julia A Callender; Yimin Yang; Gema Lordén; Natalie L Stephenson; Alexander C Jones; John Brognard; Alexandra C Newton
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-29       Impact factor: 11.205

6.  Stimulation of protein kinase C-dependent and -independent signaling pathways by bistratene A in intestinal epithelial cells.

Authors:  M R Frey; O Leontieva; D J Watters; J D Black
Journal:  Biochem Pharmacol       Date:  2001-05-01       Impact factor: 5.858

7.  Identification of the inhibitor of growth protein 4 (ING4) as a potential target in prostate cancer therapy.

Authors:  Aymen Shatnawi; Sridhar A Malkaram; Tamer Fandy; Efrosini Tsouko
Journal:  Mol Cell Biochem       Date:  2019-11-27       Impact factor: 3.396

8.  PKCalpha tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1.

Authors:  Marybeth A Pysz; Olga V Leontieva; Nicholas W Bateman; Joshua M Uronis; Kathryn J Curry; David W Threadgill; Klaus-Peter Janssen; Sylvie Robine; Anna Velcich; Leonard H Augenlicht; Adrian R Black; Jennifer D Black
Journal:  Exp Cell Res       Date:  2009-02-14       Impact factor: 3.905

9.  PDGF receptor activation induces p120-catenin phosphorylation at serine 879 via a PKCalpha-dependent pathway.

Authors:  Meredith V Brown; Patrick E Burnett; Mitchell F Denning; Albert B Reynolds
Journal:  Exp Cell Res       Date:  2008-10-11       Impact factor: 3.905

10.  PKC alpha affects cell cycle progression and proliferation in human RPE cells through the downregulation of p27kip1.

Authors:  Qianying Gao; Juan Tan; Ping Ma; Jian Ge; Yaqin Liu; Xuerong Sun; Lian Zhou
Journal:  Mol Vis       Date:  2009-12-10       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.